Metsera calls Novo Nordisk’s new bid superior to Pfizer offer
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Pfizer files second lawsuit against Novo Nordisk, Metsera
A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid Bloomberg.comNovo Nordisk bids $9bn for obesity drug maker Metsera…
Pfizer’s Q3 2025 Earnings: What to Expect
With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known…
Pfizer’s Deal on Drug Prices Is Good But Deserves Scrutiny
American taxpayers spend billions of dollars annually supporting pharmaceutical development. Yet the US continues to pay more for…
Pfizer’s new obesity bet, Metsera, releases drug data
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…
Pfizer to Cut Some Drug Prices in Deal With President Trump
Pfizer Inc. will announce plans to lower prescription drug prices at an event Tuesday alongside President Donald Trump,…
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines…
Wall Street rises to its first gain in 4 days
NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…
Stock market today: Live updates
Traders works on the floor of the New York Stock Exchange (NYSE) during morning trading on August 4,…
Pfizer Completes Licensing Agreement with 3SBio
Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizer’s innovative Oncology portfolio NEW YORK, July 24,…